CVS Health Corporation (CVS)
CVS Health Corporation provides health solutions in the United States.
Scored against other Healthcare stocks, not a fixed scale.
The quick read
CVS Health is right in the middle: the good and the not-so-good roughly cancel out.
- What's working
- It's priced lower than most other healthcare companies, relative to its sales and profits.
- Worth watching
- Its balance sheet is more stretched than most other healthcare companies.
Analyst price target
~12-month · 25 analystsPublished targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
About CVS Health Corporation
CVS Health Corporation provides health solutions in the United States…
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Employees
- 219,000
- Headquarters
- Woonsocket, RI
Similar stocks
What’s behind the score
Valuation
P/E 24.3 — lower than 68% of Healthcare peers
P/B 1.5 — lower than 93% of Healthcare peers
P/S 0.3 — lower than 93% of Healthcare peers
EV/EBITDA 10.8 — lower than 73% of Healthcare peers
EV/Revenue 0.4 — lower than 87% of Healthcare peers
PEG 0.2 — lower than 96% of Healthcare peers
FCF yield 6.8% — higher than 86% of Healthcare peers
Profitability & quality
Gross margin 13.6% — higher than 10% of Healthcare peers
Operating margin 3.9% — higher than 13% of Healthcare peers
Net margin 1.2% — higher than 13% of Healthcare peers
ROE 6.2% — higher than 19% of Healthcare peers
ROA 3.0% — higher than 7% of Healthcare peers
Free cash flow is 165% of reported net income
Financial health
Debt/equity 1.0 — lower than 19% of Healthcare peers
Current ratio 0.87 — higher than 17% of Healthcare peers
Quick ratio 0.62 — higher than 17% of Healthcare peers
Cash/debt 0.18 — higher than 45% of Healthcare peers
Debt/EBITDA 4.57 — lower than 0% of Healthcare peers
Growth
Revenue growth 7.1% YoY — higher than 43% of Healthcare peers
Earnings growth 188.8% YoY — higher than 96% of Healthcare peers
Ownership & investor activity
Payout ratio 70.0% — somewhat unusual vs Healthcare peers
Net insider selling, -81.0% of insider shares
Institutions net sold, -11.1% of shares held
Insiders hold 0.1% of shares outstanding
1.3% of float sold short
Momentum
Above its 50- & 200-day averages
56% of the way from its 52-week low to high